Business Description
Mochida Pharmaceutical Co Ltd
ISIN : JP3922800002
Total Employee Number:
1,999Description
Mochida Pharmaceutical Co Ltd is a drug manufacturing company engaged in manufacturing, procurement, and sale of pharmaceutical and healthcare-related product. The company operates in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company's pharmaceuticals business aims to develop and market a broad spectrum of creative new drugs. The healthcare segment entrusts the manufacturing of healthcare products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.11 | |||||
Equity-to-Asset | 0.77 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | 0.7 | |||||
Interest Coverage | 140.93 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.95 | |||||
Beneish M-Score | -1.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 5.9 | |||||
3-Year EBITDA Growth Rate | 8.4 | |||||
3-Year EPS without NRI Growth Rate | 7.5 | |||||
3-Year Book Growth Rate | 4.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.29 | |||||
Quick Ratio | 2.99 | |||||
Cash Ratio | 1.12 | |||||
Days Inventory | 207.21 | |||||
Days Sales Outstanding | 106.83 | |||||
Days Payable | 60.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 1 | |||||
Shareholder Yield % | 2.52 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 48.11 | |||||
Operating Margin % | 8.68 | |||||
Net Margin % | 6.76 | |||||
EBITDA Margin % | 12.16 | |||||
FCF Margin % | -8.22 | |||||
OCF Margin % | -6.01 | |||||
ROE % | 5.86 | |||||
ROA % | 4.64 | |||||
ROIC % | 6.37 | |||||
3-Year ROIIC % | 1.84 | |||||
ROC (Joel Greenblatt) % | 17.67 | |||||
ROCE % | 7.83 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 14.15 | |||||
Forward PE Ratio | 7.33 | |||||
PE Ratio without NRI | 14.12 | |||||
Shiller PE Ratio | 14.63 | |||||
PS Ratio | 0.96 | |||||
PB Ratio | 0.8 | |||||
Price-to-Tangible-Book | 0.8 | |||||
EV-to-EBIT | 8.07 | |||||
EV-to-EBITDA | 6.38 | |||||
EV-to-Revenue | 0.78 | |||||
EV-to-FCF | -9.03 | |||||
Price-to-GF-Value | 0.86 | |||||
Price-to-Projected-FCF | 0.88 | |||||
Price-to-Median-PS-Value | 0.7 | |||||
Price-to-Graham-Number | 0.71 | |||||
| Price-to-Net-Current-Asset-Value | 1.46 | |||||
Earnings Yield (Greenblatt) % | 12.39 | |||||
FCF Yield % | -8.99 | |||||
Forward Rate of Return (Yacktman) % | -2.72 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MCPMF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mochida Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 770.217 | ||
| EPS (TTM) ($) | 1.472 | ||
| Beta | -10.5542 | ||
| 3-Year Sharpe Ratio | -61.75 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | 3.64 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 9.6 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 9.6 - 9.6 | ||
| Shares Outstanding (Mil) | 35.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mochida Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mochida Pharmaceutical Co Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| JPY 42.500000 Cash Dividend | 2026-09-29 | In 80 days | ||
| JPY 40.000000 Cash Dividend | 2026-03-30 | 9.60 (+0.00%) | ||
| JPY 40.000000 Cash Dividend | 2025-09-29 | 9.60 (+0.00%) | ||
| JPY 40.000000 Cash Dividend | 2025-03-28 | 9.60 (+0.00%) |
Show
Entries
Mochida Pharmaceutical Co Ltd Frequently Asked Questions
What is Mochida Pharmaceutical Co Ltd(MCPMF)'s stock price today?
The current price of MCPMF is $9.60. The 52 week high of MCPMF is $9.60 and 52 week low is $9.60.
When is next earnings date of Mochida Pharmaceutical Co Ltd(MCPMF)?
The next earnings date of Mochida Pharmaceutical Co Ltd(MCPMF) is .
Does Mochida Pharmaceutical Co Ltd(MCPMF) pay dividends? If so, how much?
Mochida Pharmaceutical Co Ltd(MCPMF) does not pay dividend.
Guru Commentaries on OTCPK:MCPMF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Mochida Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers